News coverage of the COVID-19 pandemic in New York has lent urgency to social distancing efforts in San Antonio and South Texas, likely flattening the curve.
How has the COVID-19 pandemic affected oncology?
In Italy, the number of people dying from COVID-19 has dropped to about 500 per day—a decrease from the 900 to 1,000 patients who had been dying daily when the disease spread was at its peak.
While the world watched the pandemic unfold in China and Italy, SARS-Cov-2 spread exponentially in Spain, killing more people faster and earlier within a month, relative to many outbreaks in other Western countries.
As he manages the logistics of running Rutgers Cancer Institute of New Jersey and cancer services throughout RWJBarnabas Health, Steven K. Libutti has to worry about providing cancer care in a massive health system in the midst of the COVID-19 pandemic.
Social isolation and containment have begun to flatten the curve of COVID-19 cases in Italy, Giuseppe Curigliano said to The Cancer Letter.
This story is part of The Cancer Letter's ongoing coverage of COVID-19's impact on oncology. A full list of our coverage, as well as the latest meeting cancellations, is available here.
Week after week, Giuseppe Curigliano is waiting to see the first signs of a slowdown in Italy’s cases of COVID-19, and week after week, he is disappointed.
The Sidney Kimmel Cancer Center at Thomas Jefferson University has been developing a scalable telehealth program long before the spread of SARS-CoV-2 in the United States.
As U.S. health systems switch to telehealth to connect with patients—via phone calls and online video conferencing—during the COVID-19 pandemic, providers are quickly learning that the lack of a national infrastructure for telehealth is making it difficult to reach patients.
